|
Mr. Holubiak has been a director of the company since June 2004. Mr. Holubiak has served as the President and Chief Operating Officer for HealthSTAR Communications, Inc., the largest private marketing services company supporting the pharmaceutical industry, since August 2002. From 2001 to 2002 he was President and Chief Operating Officer and member of the Board of Directors of iPhysicianNet, Inc. (IPNI). From 1998 through 2001, he was President of Roche Laboratories, Inc., and was responsible for all U.S. operations including oversight of the market development and launch of the obesity product, Xenical, and the influenza product, Tamiflu. Previously, he was co-founder and Chief Executive Officer of Emron, Inc., a strategic marketing firm serving the pharmaceutical industry, which was acquired by Dunn & Bradstreet and IMS Health in 1995. He is the architect of the local area marketing concept for the industry and has applied that concept in both planning and execution. He is a lifetime honorary member of the Academy of Managed Care Pharmacy (AMCP), the professional society of managed care pharmacists. Since 2002 he has also served as a member of the Board of Directors for BioScrip, Inc., a publicly traded company, and the Children of Chernobyl Foundation. Mr. Holubiak received a B.S. in Molecular Biology and Biophysics from the University of Pittsburgh in 1969 and did graduate work in Biophysics at the University of Pittsburgh from 1969 to 1970. | 